There were several articles on the news this week in Canada covering the withdrawal of the drug Avandia (generic name for the drug is rosiglitazone) from the UK and it’s heavy restriction in the USA following some research showing negative side affects of the drug, an oral medication taken by an estimated 2,000,000 people globally.
The reason for the removal of the drug from the UK market has been sited as being because of links between it “raised risks of heart attacks and heart failure” according this BBC article on the subject from 23rd September. The drug also appears to be being withdrawn from the European market due to the same fears.
In America though, the Food…
Continue reading »
By
Aaron on 28 September 2010 at 9.50 am
Posted in
Science & Research
Tagged as
Avandia,
Type 2 diabetes This post has
2 comments so far.
Add yours here.